Knowledge Distillery

Filter the news according their assigned tags.
| Cross-sectional case-control studies  

Association between the risk of seizure and COVID-19 vaccinations: a self-controlled case series study

The risk of seizure following BNT162b2 and CoronaVac vaccinations has been sparsely investigated. This study aimed to evaluate this association.…

more...

COVID AND neurological diseases

| Observational study: prospective longitudinal cohort  

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

There are concerns on the safety of SARS-CoV-2 vaccination in patients with a history of Guillain-Barré syndrome (GBS), chronic inflammatory…

more...

COVID AND neurological diseases

| Case series/case reports  

Signs and symptoms of Covid-19 in patients with multiple sclerosis

Clinical outcomes of MS patients affected by Covid-19 have been deeply investigated, but a further analysis on main signs and symptoms and their risk…

more...

COVID AND neurological diseases

| Cross-sectional case-control studies  

Pre-pandemic Alzheimer Disease biomarkers and anxious-depressive symptoms during the COVID-19 confinement in cognitively unimpaired adults

Increased anxious-depressive symptomatology is observed in the preclinical stage of Alzheimer’s disease (AD), which may accelerate disease…

more...

COVID AND neurological diseases

| Cross-sectional case-control studies  

Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies

This study assessed the prevalence of anti-SARS-CoV-2 antibodies in therapeutic immunoglobulin and their impact on serological response to COVID-19…

more...

COVID AND neurological diseases

| Cross-sectional case-control studies  

Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period: A cohort study

The patterns of long-term risk of SARS-CoV-2 infection, hospitalization for COVID-19, and related death are uncertain in people with Parkinson disease…

more...

COVID AND neurological diseases

| Cross-sectional case-control studies  

BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves

COVID-19 affects the respiratory parenchyma and may potentially contribute to the tendency of myasthenia gravis (MG) patients to develop respiratory…

more...

COVID AND neurological diseases